Dr. Feiler is a Research Associate Professor and the Scientific Program Manager for the Knight Cancer Institute. Her work focuses on elucidating the genomic, transcriptional and proteomic abnormalities by which breast and pancreatic cancers arise, progress and respond to therapy. She studies the mechanisms by which these abnormalities contribute to cancer pathophysiologies and influence responses to therapy. Long-term goals are to develop strategies for earlier detection of cancers at high risk of progression to metastatic disease and more durable therapeutic approaches for advanced cancers.